Prochlorperazine Edisylate Injection
Product Images NDC 0641-6135
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 0641-6135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
West-ward Logo (Prochlorperazine Edisylate Injection 2)
This is a description of a medication called Prochlorperazine Edisylate Injection, USP. It comes in a 2 mL vial with a concentration of 10 mg per 2 mL (5 mg/mL). The medication is intended for deep IM or IV use only and is not suitable for SC use. It is important to protect it from light. The drug is manufactured by Hikma and bears a lot number code.*
Ndc 0641-6135-01 Prochlorperazine Edisylate Injection, Usp 10 mg/2 mL (5 mg/ml) Rx Only 2 mL Vial For Deep Im Or Iv Use Only Not For Sc Use Protect From Light (Prochlorperazine Edisylate Injection 3)
This is a description of Prochlorperazine Edisylate Injection, which is supplied in 25 vials with 10mg per 2mL. This medication is for deep intramuscular or intravenous use only, and should not be used subcutaneously. The vials should be discarded if they are marked or discolored. The medication appears to be manufactured by Hikma, and there is also a mention of pediatric surgery.*
Ndc 0641-6135-25 Rx Only Prochlorperazine Edisylate Injection, Usp 10 mg/2 mL (5 mg/ml) 25 X 2 mL Vials For Deep Im Or Iv Use Only Not For Subcutaneous Use Protect From Light: Keep Covered In Carton Until Time Of Use. Discard Contents If Markedly Discolored. (Prochlorperazine Edisylate Injection 4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.